In contrast, in MLL1-ELL-transduced bone marrow from recipients with established AML, Gcn1 protein was elevated without proteasome and lysosome inhibitors, and did not increase with this treatment (p = 0.07, n = 4) (Fig. 6B). The gene discussed is KMT2A; the disease is acute myeloid leukemia.